In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.

Adding polatuzumab vedotin to rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improved overall survival in transplant-ineligible patients with relapsed/refractory diffuse large B-cell ...

Patients in the low TyG index group had higher survival rates than those in the high TyG group, and this result was maintained across patient subgroups.

You've learned that you have diffuse large B-cell lymphoma (DLBCL). What happens now? A cancer diagnosis can feel overwhelming. You might not know what to do first. Start by having a conversation ...

Increased aortic TBR values before chemotherapy, particularly in patients with advanced disease, appeared to correlate with markers of vascular inflammation. A comparison of 18 F-FDG uptake between ...

The cells from that lymph node will then undergo tests to identify certain proteins or other markers under a microscope. Because DLBCL spreads quickly, it is important to get treatment as soon as ...

IVLBCL is a rare subtype of diffuse large B-cell lymphoma. Diffuse large B-cell ... can be done on biopsy samples to look for cellular markers associated with IVLBCL. IVLBCL is an aggressive ...

along with staining for B cell markers (surface proteins on B cells) to diagnose DLBCL. A doctor will likely order one of two tests to stage DLBCL. PET and CT scans are imaging tests that help ...

This helps provide targeted treatment to the cancer cells with a particular marker (CD20). Several studies found that adding rituximab to CHOP improved outcomes for people living with DLBCL ...

“Although they do not form a distinct clinicopathological entity, MYC/BCL2 double expression (DE) serves as an independent poor prognostic marker in patients with DLBCL treated with R-CHOP ...

The researchers also induced TNFAIP3 overexpression in DLBCL cells in vitro to evaluate cell proliferation, migration, and markers of apoptosis and autophagy were. This study presents a novel ...